Faris Anad Muhammad

16 ta ish

College of Pharmacy Alnoor University Nineveh Iraq

Structure‐Governed MXene Quantum Dots for Cancer Theranostics: From Quantum Confinement to Tumor‐Selective Catalytic and Photothermal Activation
Ghaleb Oriquat, Aziz Kubaev, Sanjar Usmanaliyev +5
MaqolaNanoplatforms for cancer theranosticsAdvanced Therapeutics20262 iqtibos
ABI
Nanoparticle biosensors for cardiovascular disease detection
Mohamed J. Saadh, Faris Anad Muhammad, Rafid Jihad Albadr +9
Sharh maqolaElectrochemical sensors and biosensorsClinica Chimica Acta20241 iqtibos
ABI
Structure-based design of a multi-epitope vaccine candidate against marburg virus using immunoinformatics and dynamics simulations
Mohamed J. Saadh, Faris Anad Muhammad, Rafid Jihad Albadr +9
Maqolavaccines and immunoinformatics approachesJournal of Molecular Graphics and Modelling20250 iqtibos
ABI
Inflammasomes and Cardiovascular Disease: Linking Inflammation to Cardiovascular Pathophysiology
Mohamed J. Saadh, Faris Anad Muhammad, Rafid Jihad Albadr +9
Sharh maqolaInflammasome and immune disordersScandinavian Journal of Immunology20250 iqtibos
ABI
Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer’s Disease
Mohamed J. Saadh, Faris Anad Muhammad, Tuqa S. Alazzawi +5
Sharh maqolaMicroRNA in disease regulationMolecular Neurobiology20250 iqtibos
ABI
Regulatory T Cells in Colon Cancer: Implications for Pathogenesis, Prognosis and Emerging Therapeutic Strategies
Faris Anad Muhammad, Abdulkareem Shareef, S. Renuka Jyothi +10
Sharh maqolaT-cell and B-cell ImmunologyImmunological Investigations20250 iqtibos
ABI
From protein to immunology: comprehensive insights into Marburg virus vaccines, mechanism, and application
Mohamed J. Saadh, Faris Anad Muhammad, Rafid Jihad Albadr +9
Sharh maqolaViral Infections and Outbreaks ResearchArchives of Microbiology20250 iqtibos
ABI
Exosomal non-coding RNAs: key regulators of inflammation-related cardiovascular disorders
Mohamed J. Saadh, Faris Anad Muhammad, Rafid Jihad Albadr +9
Sharh maqolaExtracellular vesicles in diseaseEuropean journal of medical research20250 iqtibos
ABI
Macrophage migration inhibitory factor (MIF): a Janus-faced cytokine in viral pathogenesis and host defense
Mohamed J. Saadh, Faris Anad Muhammad, Abdulkareem Shareef +9
Sharh maqolaMacrophage Migration Inhibitory FactorImmunologic Research20250 iqtibos
ABI
Extracellular vesicles in cardiovascular disease: Biomarkers, therapeutic applications, and drug delivery strategies
Qamar Abuhassan, Ali Salajegheh, Faris Anad Muhammad +10
MaqolaExtracellular vesicles in diseaseClinica Chimica Acta20260 iqtibos
ABI
Exosomal CeRNAs from the tumor microenvironment: hidden drivers of colorectal cancer progression
Faris Anad Muhammad, Abdulkareem Shareef, S. Renuka Jyothi +9
MaqolaExtracellular vesicles in diseaseJournal of Molecular Histology20260 iqtibos
ABI
<scp>MXene</scp> Quantum Dot–Enabled Biosensing of Metabolic Biomarkers in Cardiovascular and Metabolic Diseases: Biological Context and Translational Perspectives
Bayan Abdel Majeed, Jasur Rizaev, Zulfiya Nazirova +5
MaqolaMXene and MAX Phase MaterialsEngineering Reports20260 iqtibos
ABI
Overcoming conditional immune resistance in MSS and pMMR colorectal cancer: A sequential gating framework for immunotherapy
Husni Farah, Djamila Polatova, Jasur Rizaev +5
MaqolaCancer Immunotherapy and BiomarkersCritical Reviews in Oncology/Hematology20260 iqtibos
ABI
Antibody therapies in glioblastoma: Overcoming micro-environmental barriers.
Moeen F. Dababneh, Faris Anad Muhammad, Abdulkareem Shareef +10
MaqolaGlioma Diagnosis and TreatmentPubMed20260 iqtibos
ABI
Acute myeloid leukemia in HIV-positive patients: biological crossroads and therapeutic Hurdles
Mohamed J. Saadh, Faris Anad Muhammad, Rafid Jihad Albadr +9
MaqolaAcute Myeloid Leukemia ResearchClinical and Experimental Medicine20260 iqtibos
ABI
Toxicological and Immunological Evaluation of MXene Quantum Dots for Nanomedicine Applications
Ghada Al‐Assi, Djaloliddin Mansurov, Bilim Terebaev +5
MaqolaMXene and MAX Phase MaterialsJournal of Applied Toxicology20260 iqtibos
ABI